KRTL BioTech

Activist fund Engaged Capital may turn to a familiar strategy to boost performance at Quotient

Activist fund Engaged Capital may turn to a familiar strategy to boost performance at Quotient

Engaged Capital recently sent a letter to Quotient Technology’s board, calling out its underperformance versus its peers.